GSK · SUB~ · PE · CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE II ~0.92' «GLAXOSMITHKLINE PERU S.A.» ↔ SEC GSK (CIK 1131399, GSK plc): 8 non-competitive contracts at the buyer «CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD», 7,505,450 PEN (≈ $2,026,472); one bid, method direct (Contratación Directa); OCID ocds-dgv273-seacev3-710645, ocds-dgv273-seacev3-732393, ocds-dgv273-seacev3-871771, ocds-dgv273-seacev3-786980, ocds-dgv273-seacev3-926244, ocds-dgv273-seacev3-983565, ocds-dgv273-seacev3-2019-10215-50, ocds-dgv273-seacev3-1079912; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject

GSK · SUB~ · PE · CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD

Indicator

Debarred / sanctioned abroad × US SEC issuer

Amount

2,026,472

Records behind the indicator

8

Found

4 October 2026

Code

W-02941

Reference

ocds-dgv273-seacev3-710645

Reference

ocds-dgv273-seacev3-732393

Reference

ocds-dgv273-seacev3-871771

Reference

ocds-dgv273-seacev3-786980

Reference

ocds-dgv273-seacev3-926244

Reference

ocds-dgv273-seacev3-983565

Reference

ocds-dgv273-seacev3-2019-10215-50

Reference

ocds-dgv273-seacev3-1079912